Immunic Inc. (IMUX) Misses Q4 EPS by 303c

Immunic Inc. (NASDAQ: IMUX) reported Q4 EPS of ($3.78), $3.03 worse than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• AeroVironment restates quarterly financials, citing $89M goodwill error